Q3 2024 Management View CEO Matt Gline highlighted 2025 as a year of major milestones, focusing on validating the anti-FcRn franchise with upcoming MG and CIDP data and a central registrational ...
Q4 2024 Management View Co-CEO Roy Mann highlighted significant financial and operational achievements, including total revenue of $216.9 million in Q1 2024, representing a 34% year-over-year growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback